Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.

Nuvoli B, Germoni S, Morosetti C, Santoro R, Cortese G, Masi S, Cordone I, Galati R.

Mol Cancer. 2014 Mar 21;13:69. doi: 10.1186/1476-4598-13-69.

PMID:
24655565
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.

Zhang Y, He J, Zhang F, Li H, Yue D, Wang C, Jablons DM, He B, Lui N.

J Exp Clin Cancer Res. 2013 Feb 5;32:7. doi: 10.1186/1756-9966-32-7.

PMID:
23379358
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.

Kwan HT, Chan DW, Cai PC, Mak CS, Yung MM, Leung TH, Wong OG, Cheung AN, Ngan HY.

PLoS One. 2013;8(1):e53597. doi: 10.1371/journal.pone.0053597. Epub 2013 Jan 2.

PMID:
23301094
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.

Shen DW, Pouliot LM, Hall MD, Gottesman MM.

Pharmacol Rev. 2012 Jul;64(3):706-21. doi: 10.1124/pr.111.005637. Epub 2012 Jun 1. Review.

PMID:
22659329
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.

Carbone M, Yang H.

Clin Cancer Res. 2012 Feb 1;18(3):598-604. doi: 10.1158/1078-0432.CCR-11-2259. Epub 2011 Nov 7.

PMID:
22065079
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.

Pershouse MA, Smartt AM, Schwanke C, Putnam EA.

Genomics. 2009 Aug;94(2):101-9. doi: 10.1016/j.ygeno.2009.04.009. Epub 2009 May 13.

PMID:
19446018
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk